Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events. / Roitmann, Eva; Eriksson, Robert; Brunak, Søren.

In: Frontiers in Physiology, Vol. 5, 332, 11.09.2014.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Roitmann, E, Eriksson, R & Brunak, S 2014, 'Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events', Frontiers in Physiology, vol. 5, 332. https://doi.org/10.3389/fphys.2014.00332

APA

Roitmann, E., Eriksson, R., & Brunak, S. (2014). Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events. Frontiers in Physiology, 5, [332]. https://doi.org/10.3389/fphys.2014.00332

Vancouver

Roitmann E, Eriksson R, Brunak S. Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events. Frontiers in Physiology. 2014 Sep 11;5. 332. https://doi.org/10.3389/fphys.2014.00332

Author

Roitmann, Eva ; Eriksson, Robert ; Brunak, Søren. / Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events. In: Frontiers in Physiology. 2014 ; Vol. 5.

Bibtex

@article{e9ba74a7a7a54f2a95cfddc75d5bb432,
title = "Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events",
abstract = "PURPOSE: New pharmacovigilance methods are needed as a consequence of the morbidity caused by drugs. We exploit fine-grained drug related adverse event information extracted by text mining from electronic medical records (EMRs) to stratify patients based on their adverse events and to determine adverse event co-occurrences.METHODS: We analyzed the similarity of adverse event profiles of 2347 patients extracted from EMRs from a mental health center in Denmark. The patients were clustered based on their adverse event profiles and the similarities were presented as a network. The set of adverse events in each main patient cluster was evaluated. Co-occurrences of adverse events in patients (p-value < 0.01) were identified and presented as well.RESULTS: We found that each cluster of patients typically had a most distinguishing adverse event. Examination of the co-occurrences of adverse events in patients led to the identification of potentially interesting adverse event correlations that may be further investigated as well as provide further patient stratification opportunities.CONCLUSIONS: We have demonstrated the feasibility of a novel approach in pharmacovigilance to stratify patients based on fine-grained adverse event profiles, which also makes it possible to identify adverse event correlations. Used on larger data sets, this data-driven method has the potential to reveal unknown patterns concerning adverse event occurrences.",
author = "Eva Roitmann and Robert Eriksson and S{\o}ren Brunak",
year = "2014",
month = sep,
day = "11",
doi = "10.3389/fphys.2014.00332",
language = "English",
volume = "5",
journal = "Frontiers in Physiology",
issn = "1664-042X",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events

AU - Roitmann, Eva

AU - Eriksson, Robert

AU - Brunak, Søren

PY - 2014/9/11

Y1 - 2014/9/11

N2 - PURPOSE: New pharmacovigilance methods are needed as a consequence of the morbidity caused by drugs. We exploit fine-grained drug related adverse event information extracted by text mining from electronic medical records (EMRs) to stratify patients based on their adverse events and to determine adverse event co-occurrences.METHODS: We analyzed the similarity of adverse event profiles of 2347 patients extracted from EMRs from a mental health center in Denmark. The patients were clustered based on their adverse event profiles and the similarities were presented as a network. The set of adverse events in each main patient cluster was evaluated. Co-occurrences of adverse events in patients (p-value < 0.01) were identified and presented as well.RESULTS: We found that each cluster of patients typically had a most distinguishing adverse event. Examination of the co-occurrences of adverse events in patients led to the identification of potentially interesting adverse event correlations that may be further investigated as well as provide further patient stratification opportunities.CONCLUSIONS: We have demonstrated the feasibility of a novel approach in pharmacovigilance to stratify patients based on fine-grained adverse event profiles, which also makes it possible to identify adverse event correlations. Used on larger data sets, this data-driven method has the potential to reveal unknown patterns concerning adverse event occurrences.

AB - PURPOSE: New pharmacovigilance methods are needed as a consequence of the morbidity caused by drugs. We exploit fine-grained drug related adverse event information extracted by text mining from electronic medical records (EMRs) to stratify patients based on their adverse events and to determine adverse event co-occurrences.METHODS: We analyzed the similarity of adverse event profiles of 2347 patients extracted from EMRs from a mental health center in Denmark. The patients were clustered based on their adverse event profiles and the similarities were presented as a network. The set of adverse events in each main patient cluster was evaluated. Co-occurrences of adverse events in patients (p-value < 0.01) were identified and presented as well.RESULTS: We found that each cluster of patients typically had a most distinguishing adverse event. Examination of the co-occurrences of adverse events in patients led to the identification of potentially interesting adverse event correlations that may be further investigated as well as provide further patient stratification opportunities.CONCLUSIONS: We have demonstrated the feasibility of a novel approach in pharmacovigilance to stratify patients based on fine-grained adverse event profiles, which also makes it possible to identify adverse event correlations. Used on larger data sets, this data-driven method has the potential to reveal unknown patterns concerning adverse event occurrences.

U2 - 10.3389/fphys.2014.00332

DO - 10.3389/fphys.2014.00332

M3 - Journal article

C2 - 25249979

VL - 5

JO - Frontiers in Physiology

JF - Frontiers in Physiology

SN - 1664-042X

M1 - 332

ER -

ID: 127248236